Call for papers open In person

Proteasome Modulation and Disease Treatment Conference in Sydney, Australia – January 2027

Official name: International Conference on Proteasome Modulation and Disease Treatment (ICPMDT)

Jan 27, 2027 Sydney, Australia
Abstract deadline December 26, 2026
45days
–hours
–min
Submit on the conference website
DatesJan 27, 2027
Abstract deadlineDec 26, 2026
Organized byiPHARMA Conferences
Event ID1493816

About this conference

This medical and health sciences conference takes place in Sydney, Australia on Jan 27, 2027. Abstracts and papers are due by December 26, 2026. It is one of 1021 upcoming conferences in Australia; the next one after it starts on January 27. It is organized by iPHARMA Conferences.

This conference prioritizes the essential knowledge on proteasome modulation's impact in treating diseases. Researchers and clinicians are invited to present their studies and methodologies focusing on the proteasome's role in disease treatment, with particular attention to new pharmacological strategies. Submissions will include original research papers, practical workshops, and poster presentations that can enrich the understanding of proteasome dynamics. The agenda features engaging discussions led by field leaders, emphasizing translation from basic science to clinical application. Participants will have opportunities to network, fostering collaboration to further innovations in treatment approaches related to proteasome function. This meeting serves an important role in pushing forward the conversation on therapeutic strategies informed by proteasome research, making it a crucial event for academics and practitioners alike.

Topics

Medical and Health Sciences Biotechnology Pain Management Pharmacy

Key dates

  1. Abstract deadline · Dec 26, 202645 days left
  2. Conference · Jan 27, 2027Sydney, Australia

Details come from the organizer. Please check dates, fees and venue on the conference website before you register or travel.

More conferences in Sydney